2020
DOI: 10.1016/j.celrep.2020.107745
|View full text |Cite
|
Sign up to set email alerts
|

Phospho-Ser784-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer

Abstract: Highlights d DNA damage-induced p-Ser 784 -VCP enhances chromatinassociated protein degradation d p-Ser 784 -VCP has reduced interaction with NPL4/UFD1 and polyubiquitinated substrates d VCP phosphorylation on Ser 784 is important for DNA damage response and cell survival d p-Ser 784 -VCP correlates with poor survival of chemotherapytreated cancer patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

5
29
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 25 publications
(34 citation statements)
references
References 83 publications
5
29
0
Order By: Relevance
“…In comparison, the rescuing abilities of these two VCP mutants with regard to the buildup of nucleoplasmic K48-polyubiquitin do not differ significantly. 7 These findings are consistent with the well-known importance of VCP for chromatin-associated degradation during DDR and suggest that Ser 784 phosphorylation may be a selective functional accelerator in this regard ( Figure 1b ). However, the potential effects of Ser 784 phosphorylation on soluble nuclear proteins cannot be ruled out.…”
supporting
confidence: 88%
See 4 more Smart Citations
“…In comparison, the rescuing abilities of these two VCP mutants with regard to the buildup of nucleoplasmic K48-polyubiquitin do not differ significantly. 7 These findings are consistent with the well-known importance of VCP for chromatin-associated degradation during DDR and suggest that Ser 784 phosphorylation may be a selective functional accelerator in this regard ( Figure 1b ). However, the potential effects of Ser 784 phosphorylation on soluble nuclear proteins cannot be ruled out.…”
supporting
confidence: 88%
“…However, this theory remained untested for 15 years until our recent study. 7 Similar to Livingstone et al 4 we serendipitously detected pSer 784 -VCP in human breast cancer samples using a crossreacting phospho-PFN1 antibody. Motivated by the chemotherapy-dependent correlation with patient survival, we identified the unknown nuclear antigen of the phospho-PFN1 antibody to be pSer 784 -VCP.…”
supporting
confidence: 72%
See 3 more Smart Citations